Largest pharmaceutical companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by cash on hand, at ZAR 341.7B, ahead of Merck & Co (ZAR 252.5B) and Novartis (ZAR 198.3B). Figures as of 19 Nov 2026, 04:17 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonZAR 341.7B
- Median
- ZAR 9.9B
- Combined market value
- ZAR 87.71T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | ZAR 341.7B | ZAR 11.38T | ZAR 4,727.99 | 2.15% down | 38% up | ||
| 2 | Merck & CoMRK · Health Care | ZAR 252.5B | ZAR 5.89T | ZAR 2,388.79 | 3.90% down | 51% up | ||
| 3 | NovartisNVS · Health Care | ZAR 198.3B | ZAR 5.08T | ZAR 2,690.98 | 2.46% down | 25% up | ||
| 4 | Bristol-Myers SquibbBMY · Health Care | ZAR 177B | ZAR 2.11T | ZAR 1,032.63 | 2.92% down | 34% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | ZAR 147.8B | ZAR 3.14T | ZAR 1,811.44 | 0.22% down | 17% down | ||
| 6 | SanofiSNY · Health Care | ZAR 147.3B | ZAR 1.96T | ZAR 816.95 | 0.86% down | 4% down | ||
| 7 | Eli LillyLLY · Health Care | ZAR 126B | ZAR 21.35T | ZAR 23,973.70 | 2.32% down | 35% up | ||
| 8 | AstraZenecaAZN · Health Care | ZAR 99B | ZAR 4.81T | ZAR 3,099.29 | 1.93% down | 2% up | ||
| 9 | AbbVieABBV · Health Care | ZAR 90.7B | ZAR 8.77T | ZAR 4,958.76 | 2.33% down | 26% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 88.2B | ZAR 2.36T | ZAR 9,300.81 | 0.42% up | 27% up | ||
| 11 | BeOne MedicinesONC · Health Care | ZAR 78.8B | ZAR 799.3B | ZAR 6,997.50 | 2.34% down | 17% up | ||
| 12 | GSKGSK · Health Care | ZAR 78.2B | ZAR 1.69T | ZAR 842.27 | 1.34% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | ZAR 68.1B | ZAR 3.01T | ZAR 683.63 | 3.12% down | 17% down | ||
| 14 | Takeda PharmaceuticalTAK · Health Care | ZAR 64.6B | ZAR 1.18T | ZAR 368.77 | 1.71% down | 54% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | ZAR 61.7B | ZAR 854.3B | ZAR 732.17 | 0.92% down | 74% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 54.1B | ZAR 1.7T | ZAR 16,393.32 | 1.28% down | 36% up | ||
| 17 | ZoetisZTS · Health Care | ZAR 40.1B | ZAR 602.8B | ZAR 1,483.59 | 2.50% up | 29% down | ||
| 18 | GenmabGMAB · Health Care | ZAR 29.7B | ZAR 544.9B | ZAR 883.70 | 1.91% down | 70% up | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 28.7B | ZAR 346.9B | ZAR 2,590.25 | 4.54% down | 66% down | ||
| 20 | United TherapeuticsUTHR · Health Care | ZAR 27B | ZAR 426.3B | ZAR 10,009.75 | 1.16% down | 23% up | ||
| 21 | Roivant SciencesROIV · Health Care | ZAR 24.6B | ZAR 486.5B | ZAR 671.49 | 0.05% up | 90% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | ZAR 24.1B | ZAR 275.7B | ZAR 4,295.76 | 2.93% up | 37% up | ||
| 23 | ViatrisVTRS · Health Care | ZAR 22.9B | ZAR 403.1B | ZAR 351.61 | 0.83% down | 96% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 22.7B | ZAR 206.3B | ZAR 1,065.05 | 4.99% up | 11% up | ||
| 25 | PfizerPFE · Health Care | ZAR 19.8B | ZAR 2.77T | ZAR 486.50 | 1.44% down | 14% up | ||
| 26 | PTC TherapeuticsPTCT · Health Care | ZAR 17.1B | ZAR 87.2B | ZAR 1,044.25 | 0.22% down | 20% down | ||
| 27 | GrifolsGRFS · Health Care | ZAR 15.9B | ZAR 99.9B | ZAR 146.85 | 1.85% down | 1% up | ||
| 28 | Legend BiotechLEGN · Health Care | ZAR 15.6B | ZAR 54.6B | ZAR 281.74 | 0.87% up | 42% down | ||
| 29 | Ascendis PharmaASND · Health Care | ZAR 11.9B | ZAR 307.4B | ZAR 4,686.90 | 0.32% down | 28% up | ||
| 30 | Royalty PharmaRPRX · Health Care | ZAR 10.7B | ZAR 684.6B | ZAR 1,190.58 | 0.01% down | 78% up | ||
| 31 | ABIVAXABVX · Health Care | ZAR 9.9B | ZAR 127.2B | ZAR 1,453.42 | 2.11% up | 27% down | ||
| 32 | BridgeBio PharmaBBIO · Health Care | ZAR 9.9B | ZAR 263.5B | ZAR 1,352.51 | 1.58% up | 17% up | ||
| 33 | Elanco Animal HealthELAN · Health Care | ZAR 9.4B | ZAR 231.4B | ZAR 462.92 | 3.29% up | 20% up | ||
| 34 | InsmedINSM · Health Care | ZAR 8.8B | ZAR 455.7B | ZAR 2,077.06 | 1.69% down | 40% down | ||
| 35 | AlkermesALKS · Health Care | ZAR 6.7B | ZAR 136.5B | ZAR 812.27 | 3.08% up | 58% up | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | ZAR 6.5B | ZAR 79.1B | ZAR 474.88 | 1.59% up | 64% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | ZAR 6.2B | ZAR 147.9B | ZAR 5,291.29 | 0.04% up | 61% up | ||
| 38 | Belite BioBLTE · Health Care | ZAR 6.1B | ZAR 110B | ZAR 2,708.67 | 0.94% down | 31% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | ZAR 5.6B | ZAR 122.2B | ZAR 2,323.25 | 1.43% down | 7% down | ||
| 40 | Cogent BiosciencesCOGT · Health Care | ZAR 5.4B | ZAR 83.9B | ZAR 482.16 | 0.14% down | 20% down | ||
| 41 | Mirum PharmaceuticalsMIRM · Health Care | ZAR 5.1B | ZAR 104.7B | ZAR 1,603.56 | 0.59% up | 31% up | ||
| 42 | Amneal PharmaceuticalsAMRX · Health Care | ZAR 4.9B | ZAR 132.2B | ZAR 379.35 | 3.60% up | 83% up | ||
| 43 | Definium TherapeuticsDFTX · Health Care | ZAR 4.5B | ZAR 69.1B | ZAR 504.87 | 0.88% down | 169% up | ||
| 44 | Arrowhead PharmaceuticalsARWR · Health Care | ZAR 3.9B | ZAR 105.7B | ZAR 747.43 | 0.28% up | 10% up | ||
| 45 | Summit TherapeuticsSMMT · Health Care | ZAR 3.9B | ZAR 145.6B | ZAR 182.05 | 1.59% down | 36% down | ||
| 46 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 3.4B | ZAR 160.3B | ZAR 6,901.79 | 5.67% down | 24% down | ||
| 47 | Ligand PharmaceuticalsLGND · Health Care | ZAR 3B | ZAR 103.6B | ZAR 5,178.94 | 1.67% up | 43% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | ZAR 2.9B | ZAR 129.5B | ZAR 1,647.95 | 0.06% down | 126% up | ||
| 49 | Dr. Reddy's LaboratoriesRDY · Health Care | ZAR 2.8B | ZAR 216.5B | ZAR 259.72 | 1.28% up | 5% up | ||
| 50 | Protagonist TherapeuticsPTGX · Health Care | ZAR 2.2B | ZAR 143.9B | ZAR 2,204.66 | 2.00% up | 46% up | ||
| 51 | CytokineticsCYTK · Health Care | ZAR 2.1B | ZAR 123.9B | ZAR 889.77 | 0.64% down | 20% down | ||
| 52 | Corcept TherapeuticsCORT · Health Care | ZAR 2.1B | ZAR 128.6B | ZAR 1,175.32 | 3.25% down | 8% down | ||
| 53 | Travere TherapeuticsTVTX · Health Care | ZAR 1.6B | ZAR 83.6B | ZAR 871.05 | 1.68% down | 44% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | ZAR 1.5B | ZAR 167.1B | ZAR 1,759.08 | 8.15% up | 286% up | ||
| 55 | TG TherapeuticsTGTX · Health Care | ZAR 1.4B | ZAR 173.3B | ZAR 1,146.37 | 5.44% up | 107% up | ||
| 56 | ErascaERAS · Health Care | ZAR 1.3B | ZAR 83.7B | ZAR 238.57 | 0.94% down | 403% up | ||
| 57 | Edgewise TherapeuticsEWTX · Health Care | ZAR 1.1B | ZAR 78.5B | ZAR 717.26 | 1.59% down | 88% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 941.5M | ZAR 143.1B | ZAR 2,063.88 | 2.08% up | 13% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | ZAR 885.7M | ZAR 82B | ZAR 1,456.02 | 3.45% down | 113% up | ||
| 60 | Oruka TherapeuticsORKA · Health Care | ZAR 813.7M | ZAR 112.6B | ZAR 1,659.91 | 0.60% down | 241% up | ||
| 61 | VeradermicsMANE · Health Care | ZAR 377.4M | ZAR 91.3B | ZAR 2,164.79 | 0.62% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.3377 ZAR).
Questions and answers
Which pharmaceutical companies rank first by cash on hand?
Johnson & Johnson (ZAR 341.7B), Merck & Co (ZAR 252.5B) and Novartis (ZAR 198.3B) are the top three of the 61 pharmaceutical companies ranked by cash on hand as of 19 Nov 2026, 04:17 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by cash on hand.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by cash on hand have a combined market value of ZAR 87.71T as of 19 Nov 2026, 04:17 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by cash on hand”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.